Form S-3 Senti Biosciences Holdings Inc For: 18 June
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Senti Biosciences Holdings Inc (SNTI)
The Senti Biosciences share price today is 1.0900, view NASDAQ SNTI stock exchange data. Track the latest Senti Biosciences share price with real-time updates on SNTI stock performance including market cap, day range, 52-week range and dividend yield. Access SNTI charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.0550
1.1500
52 wk Range
0.7702
2.8800
SNTI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.05501.1500
52 wk Range
0.77022.8800
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SNTI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
13.0000
Upside
+1,092.66%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 13D/A Senti Biosciences For: 4 May
- Investing.com
- Form S-3 Senti Biosciences Holdings Inc For: 18 June
- Investing.com
- Form 8K Senti Biosciences Inc For: 14 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 13.0000
(+1,092.66% Upside)
Earnings
Latest Release
14-05-2026
EPS / Forecast
-0.14 / -0.42
Revenue / Forecast
-- / --
Compare SNTI to Peers and Sector
Metrics to compare | SNTI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSNTIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | −5.3x | −0.4x | |
PEG Ratio | −0.01 | −0.07 | 0.00 | |
Price/Book | 13.2x | 2.6x | 2.6x | |
Price / LTM Sales | 893.4x | 10.7x | 3.0x | |
Upside (Analyst Target) | - | 106.3% | 56.9% | |
Fair Value Upside | Unlock | 3.4% | 9.3% | Unlock |
Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company’s lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications with unmet need. It offers SENTI-202, a logic gated off-the-shelf CAR-NK cell therapy for the treatment of blood cancers and relapsed/refractory hematological malignancies, including acute myeloid leukemia. In addition, the company develops the tumor-associated antigen and protective antigen paired discovery platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. Further, its pipeline includes preclinical programs, which comprise a solid tumor cell therapy program; and partnered programs related to cell therapies for regenerative medicines. The company has a strategic collaboration with Celest Therapeutics (Shanghai) Co. Ltd. The company was formerly known as Senti Biosciences, Inc. and changed its name to Senti Biosciences Holdings, Inc. in April 2026. The company was incorporated in 2016 and is headquartered in South San Francisco, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Senti Biosciences (SNTI) Share Price Today?
The Senti Biosciences share price today is 1.0900.
What is the current Senti Biosciences (SNTI) share price and day range?
As of 27-06-2026, the Senti Biosciences share price is 1.0900, with a previous close of 1.0700. The share price has ranged from 1.0550 to 1.1500 today, while the 52-week range spans from 0.7702 to 2.8800.
What Is the Senti Biosciences Market Cap?
As of today, Senti Biosciences market cap is 33.9500M.
What Is the Senti Biosciences (SNTI) Share Price Target?
The average 12-month share price target for Senti Biosciences is 13.0000, with a high estimate of 15 and a low estimate of 12. 3 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +1,092.66% Upside potential.
What Is Senti Biosciences's Earnings Per Share (TTM)?
The Senti Biosciences EPS (TTM) is -1.8594.
When Is the Next Senti Biosciences Earnings Date?
Senti Biosciences will release its next earnings report on 18-08-2026.
From a Technical Analysis Perspective, Is SNTI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Senti Biosciences Trade On?
Senti Biosciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Senti Biosciences?
The stock symbol for Senti Biosciences is "SNTI."
How Many Times Has Senti Biosciences Stock Split?
Senti Biosciences has split 1 times.
How Many Employees Does Senti Biosciences Have?
Senti Biosciences has 39 employees.
What Is the SNTI Premarket Price?
SNTI's last pre-market stock price is 1.0425. The pre-market share volume is 1,290.0000, and the stock has changed by -0.0275, or -2.5700%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.